EP 2277595 A2 20110126 - Compounds for immunopotentiation

Title (en)

Compounds for immunopotentiation

Title (de)

Verbindungen zur Immunopotenzierung

Title (fr)

Composés pour potentialiser l'immunité

Publication

EP 2277595 A2 20110126 (EN)

Application

EP 10179748 A 20050624

Priority

EP 05791104 A 20050624
US 58265404 P 20040624
US 58809604 P 20040714
US 59045904 P 20040722
US 59971704 P 20040805
US 59959204 P 20040805
US 60085004 P 20040811
US 60300104 P 20040819
US 60386704 P 20040823
US 61207004 P 20040921
US 61496304 P 20040930

Abstract (en)

Compounds of formula I: wherein R 1 to R 5 are defined herein, for use in modulating an immune response in a subject, wherein said use comprises administering said compound to said subject, are disclosed.

IPC 8 full level

A61P 37/04 (2006.01); A61K 31/505 (2006.01); A61K 31/52 (2006.01); A61K 31/7068 (2006.01); A61K 31/708 (2006.01); A61K 45/06 (2006.01)

CPC (source: EP)

A61K 31/505 (2013.01); A61K 31/52 (2013.01); A61K 31/7068 (2013.01); A61K 31/708 (2013.01); A61K 45/06 (2013.01); A61P 1/04 (2017.12); A61P 11/06 (2017.12); A61P 25/00 (2017.12); A61P 25/02 (2017.12); A61P 31/12 (2017.12); A61P 31/14 (2017.12); A61P 31/18 (2017.12); A61P 31/22 (2017.12); A61P 35/00 (2017.12); A61P 37/00 (2017.12); A61P 37/02 (2017.12); A61P 37/04 (2017.12); A61P 37/08 (2017.12); A61P 43/00 (2017.12); Y02A 50/30 (2017.12)

Citation (applicant)

US 4806352 A 19890221 - CANTRELL JOHN L [US]
US 5026543 A 19910625 - RIJKE ERIC O [NL]
US 5026546 A 19910625 - HILGERS LUCAS A T [NL], et al
US 4547511 A 19851015 - ERIKSOO EDGAR [SE], et al
US 4738971 A 19880419 - ERIKSOO EDGAR [SE], et al
WO 9855495 A2 19981210 - DYNAVAX TECH CORP [US], et al
WO 9816247 A1 19980423 - UNIV CALIFORNIA [US], et al
US 2002164341 A1 20021107 - DAVIS HEATHER L [CA], et al
US 2002197269 A1 20021226 - LINGNAU KAREN [AT], et al
US 4689338 A 19870825 - GERSTER JOHN F [US]
US 5389640 A 19950214 - GERSTER JOHN F [US], et al
US 5268376 A 19931207 - GERSTER JOHN F [US]
US 4929624 A 19900529 - GERSTER JOHN F [US], et al
US 5266575 A 19931130 - GERSTER JOHN F [US], et al
US 5352784 A 19941004 - NIKOLAIDES NICK [US], et al
US 5494916 A 19960227 - LINDSTROM KYLE J [US], et al
US 5482936 A 19960109 - LINDSTROM KYLE J [US]
US 5346905 A 19940913 - GERSTER JOHN F [US]
US 5395937 A 19950307 - NIKOLAIDES NICK [US], et al
US 5238944 A 19930824 - SCHULTZ HELEN J [US], et al
US 5525612 A 19960611 - GERSTER JOHN F [US]
WO 9929693 A1 19990617 - MINNESOTA MINING & MFG [US]
US 81448004 A 20040329
US 76287304 A 20040121
US 58265404 P 20040624
US 74807103 A 20031229
US 6258812 B1 20010710 - BOLD GUIDO [CH], et al
US 4323581 A 19820406 - GANDER ROBERT J
WO 9835958 A1 19980820 - CIBA GEIGY AG [CH], et al
WO 0160814 A2 20010823 - SUGEN INC [US], et al
US 5883113 A 19990316 - TANG PENG CHO [US], et al
WO 9961422 A1 19991202 - SUGEN INC [US]
WO 03024978 A1 20030327 - POSTECH FOUNDATION [KR], et al
WO 03004505 A1 20030116 - DEBIOPHARM SA [CH], et al
US 5780454 A 19980714 - ADAMS JULIAN [US], et al
US 2003134846 A1 20030717 - WINDSOR WILLIAM T [US], et al
WO 9721701 A1 19970619 - JANSSEN PHARMACEUTICA NV [BE], et al
US 5621100 A 19970415 - LEWIS MICHAEL E [US], et al
WO 0132651 A1 20010510 - ASTRAZENECA AB [SE], et al
WO 0216351 A1 20020228 - COR THERAPEUTICS INC [US], et al
US 6727256 B1 20040427 - CARTER MALCOLM CLIVE [GB], et al
WO 0202552 A1 20020110 - GLAXO GROUP LTD [GB], et al
US 5457105 A 19951010 - BARKER ANDREW J [GB]
US 5616582 A 19970401 - BARKER ANDREW J [GB]
US 5770599 A 19980623 - GIBSON KIETH HOPKINSON [GB]
US 5747498 A 19980505 - SCHNUR RODNEY CAUGHREN [US], et al
WO 9630347 A1 19961003 - PFIZER [US], et al
US 2003171303 A1 20030911 - GALLOP MARK A [US], et al
WO 9720842 A1 19970612 - CENTRE NAT RECH SCIENT [FR], et al
WO 9902162 A1 19990121 - UNIV NEWCASTLE VENTURES LTD [GB], et al
WO 9517182 A1 19950629 - LILLY CO ELI [US]
WO 0179255 A1 20011025 - GENAERA CORP [US], et al
WO 8907105 A1 19890810 - KYOWA HAKKO KOGYO KK [JP]
US 5439936 A 19950808 - KELNER MICHAEL J [US], et al
WO 9418151 A1 19940818 - UNIV CALIFORNIA [US]
WO 9742949 A1 19971120 - BRISTOL MYERS SQUIBB CO [US]
WO 9813344 A1 19980402 - BRISTOL MYERS SQUIBB CO [US]
US 5554519 A 19960910 - WEBER J MARK [US], et al
WO 9804541 A1 19980205 - DONG A PHARM CO LTD [KR], et al
US 6025387 A 20000215 - YOO MOOHI [KR], et al
US 2004073044 A1 20040415 - SHARMA ARUN PRAKASH [IN], et al
WO 02062826 A1 20020815 - NOVIKOV VADIM VIKTOROVICH [RU], et al
WO 2004006834 A2 20040122 - UNITECH PHARMACEUTICALS INC [US]
US 6331555 B1 20011218 - HIRTH KLAUS P [US], et al
US 5552396 A 19960903 - HEATH JR WILLIAM F [US], et al
US 5057614 A 19911015 - DAVIS PETER D [GB], et al
WO 0230941 A2 20020418 - BRISTOL MYERS SQUIBB CO [US], et al
WO 9707081 A2 19970227 - UNIV YALE [US], et al
WO 9307153 A1 19930415 - SCHERING CORP [US]
WO 0104125 A1 20010118 - KYOWA HAKKO KOGYO KK [JP], et al
WO 9308809 A1 19930513 - UNIV SOUTHERN CALIFORNIA [US]
WO 9406799 A1 19940331 - KYOWA HAKKO KOGYO KK [JP], et al
WO 0027422 A2 20000518 - BIOGEN INC [US], et al
WO 9613506 A1 19960509 - CEPHALON INC [US], et al
WO 8807045 A1 19880922 - KYOWA HAKKO KOGYO KK [JP]
US 6284772 B1 20010904 - PITZER KEVIN K [US], et al
WO 9014837 A1 19901213 - CHIRON CORP [US]
WO 9944636 A2 19990910 - OHIO MED COLLEGE [US], et al
WO 0056358 A2 20000928 - SMITHKLINE BEECHAM BIOLOG [BE], et al
EP 0835318 A2 19980415 - SMITHKLINE BEECHAM BIOLOG [BE]
WO 9952549 A1 19991021 - SMITHKLINE BEECHAM BIOLOG [BE], et al
WO 0121207 A2 20010329 - SMITHKLINE BEECHAM BIOLOG [BE], et al
WO 0121152 A1 20010329 - SMITHKLINE BEECHAM BIOLOG [BE], et al
WO 0062800 A2 20001026 - SMITHKLINE BEECHAM BIOLOG [BE], et al
WO 0023105 A2 20000427 - SMITHKLINE BEECHAM BIOLOG [BE], et al
WO 9911241 A1 19990311 - SMITHKLINE BEECHAM BIOLOG [BE], et al
WO 9857659 A1 19981223 - SMITHKLINE BEECHAM BIOLOG [BE], et al
WO 9818931 A2 19980507 - HUMAN GENOME SCIENCES INC [US], et al
WO 9818930 A2 19980507 - HUMAN GENOME SCIENCES INC [US], et al
US 6699703 B1 20040302 - DOUCETTE-STAMM LYNN [US], et al
US 6800744 B1 20041005 - DOUCETTE-STAMM LYNN A [US], et al
WO 9743303 A1 19971120 - SMITHKLINE BEECHAM CORP [US], et al
WO 9737026 A1 19971009 - SMITHKLINE BEECHAM CORP [US], et al
WO 0234771 A2 20020502 - CHIRON SPA [IT], et al
WO 2005032582 A2 20050414 - CHIRON CORP [US], et al
WO 02094851 A2 20021128 - US GOV HEALTH & HUMAN SERV [US], et al
WO 0218595 A2 20020307 - AVENTIS PASTEUR [CA], et al
WO 9958562 A2 19991118 - SMITHKLINE BEECHAM BIOLOG [BE], et al
WO 03093306 A2 20031113 - CHIR0N SRL [IT], et al
WO 2004041157 A2 20040521 - CHIRON CORP [US], et al
WO 2005002619 A2 20050113 - CHIRON CORP [US], et al
US 5284652 A 19940208 - PIER ALLAN C [US]
US 5453273 A 19950926 - WERNER MARK [US], et al
US 6132733 A 20001017 - WERNER MARK [US], et al
US 5948413 A 19990907 - MENDOZA ALBERTO L [US]
US 6333164 B1 20011225 - TAKESAKO KAZUTOH [JP], et al
US 5693522 A 19971202 - CHADA SUNIL [US], et al
WO 9102062 A2 19910221 - TRITON BIOSCIENCES INC [US]
US 6015567 A 20000118 - HUDZIAK ROBERT MICHAEL [US], et al
WO 0108636 A2 20010208 - UNIV OHIO STATE [US]
WO 9630514 A1 19961003 - UNIV WASHINGTON [US], et al
US 5846538 A 19981208 - CHEEVER MARTIN A [US], et al
US 5869445 A 19990209 - CHEEVER MARTIN A [US], et al
US 58177200 A 20000615
WO 0022430 A2 20000420 - CHIRON CORP [US], et al
WO 9629412 A1 19960926 - IAF BIO VAC INC [CA], et al
WO 0152885 A1 20010726 - CHIRON SPA [IT], et al
GB 0016363 A 20000703
IB 0100166 W 20010117
WO 9927105 A2 19990603 - GENSET SA [FR], et al
WO 0027994 A2 20000518 - UNIV CALIFORNIA [US]
WO 0037494 A2 20000629 - CHIRON SPA [IT], et al
WO 9928475 A2 19990610 - GENSET SA [FR], et al
WO 9318150 A1 19930916 - SCLAVO BIOCINE SPA [IT]
WO 9953310 A1 19991021 - CHIRON SPA [IT], et al
WO 9804702 A2 19980205 - CHIRON BEHRING GMBH & CO [DE], et al
GB 0026333 A 20001027
GB 0028727 A 20001124
GB 0105640 A 20010307
EP 0477508 A1 19920401 - AMERICAN CYANAMID CO [US]
US 5306492 A 19940426 - PORRO MASSIMO [IT]
WO 9842721 A1 19981001 - LEES ANDREW [US], et al
EP 0372501 A2 19900613 - BEHRINGWERKE AG [DE]
EP 0378881 A1 19900725 - ENIRICERCHE SPA [IT]
EP 0427347 A1 19910515 - ENIRICERCHE SPA [IT]
WO 9317712 A2 19930916 - SCLAVO BIOCINE SPA [IT]
WO 9858668 A2 19981230 - MICROBIOLOGICAL RES AUTHORITY [GB], et al
EP 0471177 A2 19920219 - AMERICAN CYANAMID CO [US]
WO 0056360 A2 20000928 - SMITHKLINE BEECHAM BIOLOG [BE], et al
WO 0067161 A2 20001109 - GRANT LEE H [US], et al
DE 1061788 B 19590723 - CIBA GEIGY
US 59971704 P 20040805
US 60599592 P
US 60085004 P 20040811
US 60300104 P 20040819
US 60386704 P 20040823
US 61207004 P 20040921
US 61496304 P 20040930
US 59045904 P 20040722
BORG ET AL., J. CLIN. INVEST., vol. 114, 2004, pages 379 - 388
"Current Status of Immunological Adjuvants", ANN. REV. IMMUNOL., vol. 4, 1986, pages 369 - 388
DEREK T O'HAGAN; NICHOLAS M: "Recent Advances in Vaccine Adjuvants and Delivery Systems", VALIANTE
T. HIGUCHI; V. STELLA: "Pro-drugs as Novel Delivery Systems", vol. 14, A.C.S. SYMPOSIUM SERIES
"Bioreversible Carriers in Drug Design", 1987, AMERICAN PHARMACEUTICAL ASSOCIATION AND PERGAMON PRESS
GREENE, T.W.: "Protective Groups in Organic Synthesis", 1981, JOHN WILEY & SONS
"Remington's Pharmaceutical Sciences", 1991, MACK PUB. CO.
"Methods in Cell Biology", vol. XIV, 1976, ACADEMIC PRESS, pages: 3 3
LEE, DIFFUSION-CONTROLLED MATRIX SYSTEMS, pages 155 - 198
RON; LANGER: "Treatise on Controlled Drug Delivery", 1992, MARCEL DEKKER, INC., article "Erodible Systems", pages: 199 - 224
DALE, VACCINE, vol. 17, 1999, pages 193 - 200
DALE, VACCINE, vol. 14, no. 10, pages 944 - 948
INFECT IMMUN, vol. 69, no. 5, May 2001 (2001-05-01), pages 3510 - 3515
INFECT IMMUN, vol. 66, no. 5, May 1998 (1998-05-01)
ZHU ET AL., VACCINE, vol. 22, 2004, pages 660 - 669
PRICE ET AL., INFECTION AND IMMUNITY, vol. 71, no. 1, 2004, pages 277 - 283
PLANTE ET AL., J INFECTIOUS DISEASE, vol. 182, 2000, pages 848 - 855
INFECT IMMUN, vol. 70, no. 8, August 2002 (2002-08-01), pages 4414
INFECT IMMUN, vol. 71, no. 1, January 2003 (2003-01-01), pages 374 - 383
INFECT IMMUN, vol. 67, no. 10, October 1999 (1999-10-01), pages 5395
INFECT IMMUN, vol. 65, no. 11, November 1997 (1997-11-01), pages 4476 - 4482
INFECT IMMUN, vol. 72, no. 10, October 2004 (2004-10-01), pages 6148
PROC NAIL ACAD SCI USA, vol. 101, no. 34, 24 August 2004 (2004-08-24), pages 12652
INFECT IMMUN, vol. 72, no. 7, July 2004 (2004-07-01), pages 3829
BIOCHIM BIOPHYS ACTA, vol. 1702, no. 2, 1 November 2004 (2004-11-01), pages 145
INFECT IMMUN, vol. 71, no. 10, October 2003 (2003-10-01), pages 5498 - 504
INFECT IMMUN, vol. 69, no. 5, May 2001 (2001-05-01), pages 3323 - 3334
J CLIN MICROBIOL, vol. 37, no. 12, December 1999 (1999-12-01), pages 3997
CAN J BIOCHEM CELL BIOL, vol. 62, no. 5, May 1984 (1984-05-01), pages 270 - 5
BIOCONJUGATE TECHNIQUES, 1996
CRC, CHEMISTRY OFPROTEIN CONJUGATION AND CROSS-LINKING, 1993
J GEN VIROL, vol. 85, November 2004 (2004-11-01), pages 3229
HOUGHTON ET AL., HEPATOLOGY, vol. 14, 1991, pages 381
"Vaccines", 2004
"Medical Microbiology", 2002
"Virology", 1988
"Fundamental Virology", 1991
MOINGEON P: "Cancer vaccines", VACCINE, vol. 19, 2001, pages 1305 - 1326
ROSENBERG SA: "Progress in human tumor immunology and immunotherapy", NATURE, vol. 411, 2001, pages 380 - 384
DERMINE, S. ET AL.: "Cancer Vaccines and Immunotherapy", BRITISH MEDICAL BULLETIN, vol. 62, 2002, pages 149 - 162
ESPINOZA-DELGADO I.: "Cancer Vaccines", THE ONCOLOGIST, vol. 7, no. 3, 2002, pages 20 - 33
DAVIS, I.D. ET AL.: "Rational approaches to human cancer immunotherapy", JOURNAL OF LEUKOCYTE BIOLOGY, vol. 23, 2003, pages 3 - 29
VAN DEN EYNDE B ET AL.: "New tumor antigens recognized by T cells", CURR. OPIN. IMMUNOL., vol. 7, 1995, pages 674 - 81
ROSENBERG SA: "Cancer vaccines based on the identification of genes encoding cancer regression antigens", IMMUNOL. TODAY, vol. 18, 1997, pages 175 - 82
OFFRINGA R ET AL.: "Design and evaluation of antigen-specific vaccination strategies against cancer", CURRENT OPIN. IMMUNOL., vol. 2, 2000, pages 576 - 582
ROSENBERG SA: "A new era for cancer immunotherapy based on the genes that encode cancer antigens", IMMUNITY, vol. 10, 1999, pages 281 - 7
SAHIN U ET AL.: "Serological identification of human tumor antigens", CURR. OPIN. IMMUNOL., vol. 9, 1997, pages 709 - 16
OLD LJ ET AL.: "New paths in human cancer serology", J. EXP. MED., vol. 187, 1998, pages 1163 - 7
CHAUX P ET AL.: "Identification of MAGE-3 epitopes presented by HLA-DR molecules to CD4(+) T lymphocytes", J. EXP. MED., vol. 189, 1999, pages 767 - 78
GOLD P ET AL.: "Specific carcinoembryonic antigens of the human digestive system", J. EXP. MED., vol. 122, 1965, pages 467 - 8
LIVINGSTON PO ET AL.: "Carbohydrate vaccines that induce antibodies against cancer: Rationale", CANCER IMMUNOL. IMMUNOTHER., vol. 45, 1997, pages 1 - 6
LIVINGSTON PO ET AL.: "Carbohydrate vaccines that induce antibodies against cancer: Previous experience and future plans", CANCER IMMUNOL. IMMUNOTHER., vol. 45, 1997, pages 10 - 9
TAYLOR-PAPADIMITRIOU J: "Biology, biochemistry and immunology of carcinoma-associated mucins", IMMUNOL. TODAY, vol. 18, 1997, pages 105 - 7
ZHAO X-J ET AL.: "GD2 oligosaccharide: target for cytotoxic T lymphocytes", J. EXP. MED., vol. 182, 1995, pages 67 - 74
THEOBALD M ET AL.: "Targeting p53 as a general tumor antigen", PROC. NATL. ACAD. SCI. USA, vol. 92, 1995, pages 11993 - 7
GAUDERNACK G: "T cell responses against mutant ras: a basis for novel cancer vaccines", IMMUNOTECHNOLOGY, vol. 2, 1996, pages 3 - 9
TETTELIN ET AL., SCIENCE, vol. 287, 2000, pages 1809 - 1815
PIZZA ET AL., SCIENCE, vol. 287, 2000, pages 1816 - 1820
BJUNE ET AL., LANCET, vol. 338, no. 8775, 1991
FUSKASAWA ET AL., VACCINE, vol. 17, 1999, pages 2951 - 2958
ROSENQIST ET AL., DEV. BIOL. STRAND, vol. 92, 1998, pages 323 - 333
CONSTANTINO ET AL., VACCINE, vol. 10, 1992, pages 691 - 698
CONSTANTINO ET AL., VACCINE, vol. 17, 1999, pages 1251 - 1263
WATSON, PEDIATR INFECT DIS J, vol. 19, 2000, pages 331 - 332
RUBIN, PEDIATR CLIN NORTH AM, vol. 47, 2000, pages 269 - 285
JEDRZEJAS, MICROBIOL MOL BIOL REV, vol. 65, 2001, pages 187 - 207
KALMAN ET AL., NATURE GENETICS, vol. 21, 1999, pages 385 - 389
READ ET AL., NUCLEIC ACIDS RES, vol. 28, 2000, pages 1397 - 406
SHIRAI ET AL., J. INFECT. DIS, vol. 181, no. 3, 2000, pages 5524 - 5527
BELL, PEDIATR INFECT DIS J, vol. 19, 2000, pages 1187 - 1188
IWARSON, APMIS, vol. 103, 1995, pages 321 - 326
GERLICH ET AL., VACCINE, vol. 8, 1990, pages 63 - 68,79-80
HSU ET AL., CLIN LIVER DIS, vol. 3, 1999, pages 901 - 915
GASTOFSSON ET AL., N. ENGL. J. MED., vol. 334, 1996, pages 349 - 355
RAPPUOLI ET AL., TIBTECH, vol. 9, 1991, pages 232 - 238
"Vaccines", 1988
DEL GUIDICE ET AL., MOLECULAR ASPECTS OF MEDICINE, vol. 19, 1998, pages 1 - 70
ROSS ET AL., VACCINE, vol. 19, 2001, pages 135 - 142
SUTTER ET AL., PEDIATR CLIN NORTH AM, vol. 47, 2000, pages 287 - 308
ZIMMERMAN; SPANN, AM FAN PHYSICIAN, vol. 59, 1999, pages 113 - 118,125-126
DREENSEN, VACCINE, vol. 15, 1997, pages 2 - 6
MMWR MORB MORTAL WKLY REP, vol. 47, no. 1, 16 January 1998 (1998-01-16), pages 12,9
MCMICHAEL, VACCINE, vol. L9, no. 1, 2000, pages 101 - 107
SCHUCHAT, LANCER, vol. 353, no. 9146, 1999, pages 51 - 6
DALE, INFECT DISCLIN NORTH AM, vol. 13, 1999, pages 227 - 43
FERRETTI ET AL., PNAS USA, vol. 98, 2001, pages 4658 - 4663
KURODA ET AL., LANCET, vol. 357, no. 9264, 2001, pages 1225 - 1240
RAMSAY ET AL., LANCET, vol. 357, no. 9251, 2001, pages 195 - 196
LINDBERG, VACCINE, vol. 17, no. 2, 1999, pages 528 - 36
BUTTERY; MOXON, J R COIL PHYSICIANS LONG, vol. 34, 2000, pages 163 - 168
AHMAD; CHAPNICK, INFECT DIS CLIN NORTH AM, vol. 13, 1999, pages 113 - 133
GOLDBLATT, J. MED. MICROBIOL., vol. 47, 1998, pages 663 - 567
"Conjugate Vaccines", vol. 10, pages: 48 - 114
SYNTHESIS, 1997, pages 113
S.OMURA ET AL., J.ANTIBIOTICS, vol. 30, 1977, pages 275
TETRAHEDRON LETTERS, vol. 36, no. 46, 1995, pages 8383 - 6
ORGANIC LETTERS, vol. 3, no. 11, 2001, pages 1689 - 1692
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY, vol. 117, no. 1, 1995, pages 552 - 3
S.J DANISHEFSKY ET AL., J.AM.CHEM.SOC., vol. 118, 1996, pages 2825
J.L.WOOD ET AL., J.AM.CHEM.SOC., vol. 118, 1996, pages 10656
POPE ET AL., CELLULAR IMMUNOLOGY, vol. 162, 1995, pages 333 - 339
POPE ET AL., IMMUNOSTIMULATORY COMPOUND 7-ALLYL-8-OXOGUANOSINE (LOXORIBINE) INDUCES A DISTINCT SUBSET OF MURINE CYTOKINES CELLULAR IMMUNOLOGY, vol. 162, 1995, pages 333 - 339
LOHMANN ET AL., SCIENCE, vol. 285, 1999, pages 110 - 113

Citation (examination)

JYONOUCHI, H. ET AL: "Immunomodulating actions of RNA and nucleotides on muren lymphocytes in vitro: augmentation of antibody production to T dependent antigens and expansion of T helper cells", JOURNAL OF NUTRITIONAL IMMUNOLOGY, vol. 2, no. 2, 1993, pages 5 - 24, XP008155660, ISSN: 1049-5150

Designated contracting state (EPC)

AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IS IT LI LT LU MC NL PL PT RO SE SI SK TR

DOCDB simple family (publication)

WO 2006002422 A2 20060105; WO 2006002422 A3 20060713; WO 2006002422 A9 20060921; CA 2571421 A1 20060105; EP 1765313 A2 20070328; EP 2277595 A2 20110126; EP 2277595 A3 20110928; JP 2008504292 A 20080214; JP 2012184264 A 20120927

DOCDB simple family (application)

US 2005022769 W 20050624; CA 2571421 A 20050624; EP 05791104 A 20050624; EP 10179748 A 20050624; JP 2007518351 A 20050624; JP 2012148640 A 20120702